Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of <i>TP53</i> alterations and venetoclax treatment-Reference-Cited by-同舟云学术

Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of TP53 alterations and venetoclax treatment

Published:2022-09-10 Issue:13 Volume:63 Page:3105-3116
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Abbas Hussein A.¹²³⁴,Ayoub Edward¹^ORCID,Sun Hanxiao¹⁵,Kanagal-Shamanna Rashmi⁶^ORCID,Short Nicholas J.¹^ORCID,Issa Ghayas¹^ORCID,Yilmaz Musa¹^ORCID,Pierce Sherry¹,Rivera Daniel¹,Cham Brent⁷,Wing Shane⁷,Li Ziyi⁵,Hammond Danielle¹,Jabbour Elias¹,Borthakur Gautam¹^ORCID,Garcia-Manero Guillermo¹,Andreeff Michael¹,Daver Naval¹^ORCID,Kadia Tapan¹,Konopleva Marina¹,DiNardo Courtney¹^ORCID,Ravandi Farhad¹^ORCID

Affiliation:

1. Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

2. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

3. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

4. Department of Hematology and Medical Oncology, The University of Texas Health Science Center, Houston, TX, USA

5. Department of Biostatistics, Division of Basic Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

6. Department of Hematopathology, Division of Pathology-Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

7. Department of Internal Medicine, The University of Texas Health Science Center, Houston, TX, USA

Funder

Ladies Leukemia League Foundation

Conquer Cancer Foundation Young Investigator Award

MD Anderson Institutional Start-up Grant

CPRIT Training Award

NIH NCI

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2118533

Reference23 articles.

1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

2. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

3. MONOSOMY 7 IN ERYTHROLEUKÆMIA

4. DELETIONS OF CHROMOSOME 7 IN HÆMATOLOGICAL DISORDERS

5. The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TP53 status and impact on AML prognosis within the ELN 2022 risk classification;Blood;2023-12-07

2. TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA;Mediterranean Journal of Hematology and Infectious Diseases;2023-06-29

3. Molecular findings in myeloid neoplasms;International Journal of Laboratory Hematology;2023-06-21